Centric Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.82M | Hold |
27,968
| – | – | 0.91% | 28 |
|
|
2026
Q1 | $5.82M | Sell |
27,968
-161
| -0.6% | -$35.7K | 1.16% | 18 |
|
|
2025
Q4 | $6.35M | Buy |
28,129
+3,120
| +12% | +$711K | 1.34% | 16 |
|
|
2025
Q3 | $5.45M | Buy |
25,009
+1,215
| +5% | +$247K | 1.21% | 19 |
|
|
2025
Q2 | $4.71M | Buy |
23,794
+2,277
| +11% | +$423K | 1.12% | 21 |
|
|
2025
Q1 | $4.51M | Buy |
21,517
+3,261
| +18% | +$634K | 1.18% | 17 |
|
|
2024
Q4 | $3.24M | Buy |
18,256
+8,508
| +87% | +$1.56M | 0.88% | 27 |
|
|
2024
Q3 | $1.96M | Sell |
9,748
-59
| -0.6% | -$11K | 0.52% | 62 |
|
|
2024
Q2 | $1.82M | Buy |
9,807
+237
| +2% | +$39.3K | 0.52% | 57 |
|
|
2024
Q1 | $1.56M | Buy |
9,570
+409
| +4% | +$70.5K | 0.49% | 57 |
|
|
2023
Q4 | $1.57M | Buy |
9,161
+365
| +4% | +$53.2K | 0.52% | 59 |
|
|
2023
Q3 | $1.31M | Buy |
8,796
+421
| +5% | +$61.8K | 0.55% | 55 |
|
|
2023
Q2 | $1.13M | Buy |
8,375
+152
| +2% | +$22.3K | 0.45% | 58 |
|
|
2023
Q1 | $1.31M | Buy |
8,223
+419
| +5% | +$64.1K | 0.57% | 44 |
|
|
2022
Q4 | $1.26M | Sell |
7,804
-192
| -2% | -$29.4K | 0.64% | 46 |
|
|
2022
Q3 | $1.07M | Sell |
7,996
-57
| -0.7% | -$8.18K | 0.43% | 62 |
|
|
2022
Q2 | $1.23M | Buy |
8,053
+769
| +11% | +$118K | 0.45% | 64 |
|
|
2022
Q1 | $1.18M | Sell |
7,284
-82
| -1% | -$11.9K | 0.37% | 74 |
|
|
2021
Q4 | $997K | Buy |
7,366
+760
| +12% | +$89.8K | 0.33% | 74 |
|
|
2021
Q3 | $713K | Buy |
6,606
+406
| +7% | +$46.4K | 0.26% | 86 |
|
|
2021
Q2 | $698K | Sell |
6,200
-3,837
| -38% | -$432K | 0.24% | 86 |
|
|
2021
Q1 | $1.09M | Sell |
10,037
-141
| -1% | -$15.1K | 0.31% | 87 |
|
|
2020
Q4 | $1.09M | Buy |
10,178
+3,807
| +60% | +$366K | 0.34% | 76 |
|
|
2020
Q3 | $460K | Sell |
6,371
-3,796
| -37% | -$357K | 0.35% | 68 |
|
|
2020
Q2 | $998K | Buy |
10,167
+3,796
| +60% | +$334K | 0.52% | 52 |
|
|
2020
Q1 | $460K | Sell |
6,371
-462
| -7% | -$39.4K | 0.35% | 68 |
|
|
2019
Q4 | $605K | Buy |
6,833
+462
| +7% | +$38.4K | 0.48% | 50 |
|
|
2019
Q3 | $460K | Buy |
6,371
+3,198
| +101% | +$219K | 0.35% | 68 |
|
|
2019
Q2 | $231K | Sell |
3,173
-11
| -0.3% | -$865 | 0.2% | 87 |
|
|
2019
Q1 | $257K | Buy |
3,184
+532
| +20% | +$43.5K | 0.24% | 78 |
|
|
2018
Q4 | $245K | Buy |
+2,652
| New | +$233K | 0.22% | 95 |
|
Other funds holding ABBV
Centric Wealth Management's ABBV Position: Q2 2026 in Review
Centric Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 27,968 shares worth $5.82M. The position accounts for 0.91% of the portfolio, ranked #28.
Centric Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.35M in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Centric Wealth Management held 27,968 shares of AbbVie worth $5.82M as of Q2 2026.
- Centric Wealth Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.91% of Centric Wealth Management's portfolio in Q2 2026, its #28 holding.
- Centric Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Centric Wealth Management's AbbVie position peaked at $6.35M in Q4 2025.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Centric Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.